# 48 - Phase 2B Closeout
## Wise Patient Experience Platform (Batches PXP-1–PXP-8, PXP-10–PXP-11) — Version 1.0 — 2026-07-15

> Documentation-only record, produced by Batch PXP-11, Phase 2B's own closeout batch
> (docs/44 §22, docs/47 §15). No new application feature was added and no architecture
> was changed to produce this closeout. The only non-documentation-adjacent changes
> this batch made were three small, disclosed corrections to
> docs/33-DOMAIN-MODEL.md (§5 below) closing stale status tags left over from earlier
> batches — no `apps-script/*.gs` file, no `shared/schemas/*.schema.json` file, no
> `shared/constants/*.json` registry file, and no patient-facing page was touched.
> Mirrors the closeout discipline docs/27-PHASE-1.5-CLOSEOUT.md,
> docs/35-FOUNDATION-CLOSEOUT.md, docs/36-IDENTITY-AND-ACCESS-CLOSEOUT.md,
> docs/38-PATIENT-ACCESS-DASHBOARD-SHELL-CLOSEOUT.md, and
> docs/43-PHASE-2A-CLOSEOUT.md already established.

---

# 1. Phase 2B Scope

Phase 2B ("Wise Patient Experience Platform") is the platform's second real
patient-facing product layer — architecture approved in
docs/44-PHASE-2B-TECHNICAL-PLAN.md (Version 4.0), docs/45-PHASE-2B-ARCHITECTURE-READINESS-REVIEW.md
(Version 4.0), docs/46-PHASE-2B-REPOSITORY-CONSISTENCY-REVIEW.md (Version 4.0),
ADR-012 (amended twice), ADR-013 (confirmed), ADR-015 (current authentication ADR,
supersedes ADR-014, which superseded ADR-011), and ADR-016 (new, Template Registry).
Implementation was governed batch-by-batch by
docs/47-PHASE-2B-IMPLEMENTATION-RULES.md, the permanent per-batch process standard
this phase introduced. Eleven named batch slots (docs/44 §22), of which nine were
built, one was deliberately left an unbuilt reserved placeholder, and one is this
closeout itself:

- **PXP-1 — Patient Profile** (shipped 2026-07-09) — the platform's first
  patient-mutable, upsert-style entity.
- **PXP-2 — Doctor-Assigned Conditions** (shipped 2026-07-09) — Pillar 1.
- **PXP-3 — Module Registry** (shipped 2026-07-10) — Pillar 2, backend.
- **PXP-4 — Dashboard Registry** (shipped 2026-07-11) — Pillar 2, frontend consumer.
- **PXP-5 — Daily Check-in Engine** (shipped 2026-07-12) — Template Registry (new
  ADR-016) + its first concrete category.
- **PXP-6 — Calculator Registry** (shipped 2026-07-13) — Pillar 3, backend only,
  disclosed scope narrowing.
- **PXP-7 — Personal Care Plan** (shipped 2026-07-14) — doctor-authored, read-only
  to the patient.
- **PXP-8 — Trusted Device + Long-Lived Session** (shipped 2026-07-14) — Persistent
  Authentication; optional PIN explicitly out of scope, gated separately.
- **PXP-9 — AI Integration** — **intentionally unbuilt, reserved placeholder.**
  docs/44 §22 names it "nothing concrete"; docs/45 independently found it "not ready
  for any scoping at all." Building anything under this name would mean inventing an
  unapproved AI feature outside the ADR-001/004/005/013 gate docs/44 §15 requires.
  Its slot stays reserved for a future, separately-proposed AI Integration design —
  never silently renumbered or repurposed by any batch in this sequence.
- **PXP-10 — Symptom Tracker Migration** (shipped 2026-07-15) — approved and built
  directly after PXP-8, since docs/44 §22's own dependency column names only "PXP-5
  proven in production" as its prerequisite, not PXP-9.
- **PXP-11 — Closeout** (this batch) — validation-suite re-run, documentation
  closeout, repository consistency review, release audit.

---

# 2. What This Batch Did

Per its own charter (docs/44 §22's PXP-11 row: "Validation-suite build-out for every
entity above + documentation closeout"; docs/47 §13's three-phase workflow), this
batch:

1. Confirmed the branch is based on the latest `main` (PR #54 merged, PXP-9's
   intentional-skip decision and PXP-10 included), the repository is clean, and
   PXP-1 through PXP-8 plus PXP-10 remain frozen with zero code drift.
2. Read docs/CLAUDE.md's required order, docs/44, docs/45, docs/46, and
   docs/47 in full before writing anything.
3. Re-ran every existing validation suite fresh, with zero code changes: static
   analysis, conformance, Phase 1.5 regression, and all ten browser-test suites (§3).
4. Performed a repository consistency review against docs/47 §14's checklist
   (architecture, schema, contract, ADR, documentation, validation, and hygiene
   consistency) and fixed the three genuine, disclosed, documentation-only
   inconsistencies it found (§5).
5. Confirmed no mandated security review was left pending — unlike Phase 2A's
   magic-link review (caught late, at PA-7 closeout), Phase 2B's one genuinely new
   authentication mechanism (Trusted Device + Long-Lived Session, PXP-8) already has
   its own dedicated review recorded in docs/15-SECURITY-STANDARDS.md at the time it
   shipped (§6) — nothing was deferred to this closeout to discover.
6. Updated docs/24-ROADMAP.md and the root `CHANGELOG.md` to record PXP-11 itself and
   Phase 2B's overall closed status (§8).

---

# 3. Validation Summary (fresh re-run, this batch)

| Suite | Result |
|---|---|
| `node validation/static-analysis/analyze.js` | PASS — 0 findings (44 `apps-script/*.gs` files scanned) |
| `node validation/phase-2a-foundation/conformance.js` | PASS — 419/419 |
| `node validation/phase-1-5/validate.js` | PASS — 42/42 |
| `validation/pa-2-dashboard/browser-test.js` | PASS — 30/30 |
| `validation/pa-3-timeline/browser-test.js` | PASS — 29/29 |
| `validation/pa-4-symptom-tracker/browser-test.js` | PASS — 21/21 |
| `validation/pa-5-reports/browser-test.js` | PASS — 32/32 |
| `validation/pa-6-public-nav/browser-test.js` | PASS — 22/22 |
| `validation/pxp-1-patient-profile/browser-test.js` | PASS — 25/25 |
| `validation/pxp-4-dashboard-registry/browser-test.js` | PASS — 23/23 |
| `validation/pxp-5-checkin-engine/browser-test.js` | PASS — 25/25 |
| `validation/pxp-7-care-plan-engine/browser-test.js` | PASS — 17/17 |
| `validation/pxp-8-persistent-login/browser-test.js` | PASS — 25/25 |

**710 automated checks across 13 suites, 0 failures.** No suite required a code
change to pass — every result above was already true going into this batch; this
batch's job was to prove it fresh, together, as one platform, not to fix anything.

Three batches (PXP-2, PXP-3, PXP-6) deliberately introduce no browser-test suite of
their own — each ships a doctor/staff-only, editor-run capability or a backend-only
registry scaffold with no patient-facing (or browser-drivable) surface, a disclosed
scope decision recorded in that batch's own CHANGELOG entry and re-confirmed, not
just re-read, by this closeout's own review of each entity's actual patient-facing
footprint (§5's review dimensions). This mirrors `PatientIdentity.gs`'s own
editor-only precedent from Phase 2A. Every entity that does have a patient- or
doctor-facing surface has one.

---

# 4. Frozen-File Boundary Confirmation

`git diff` between this branch and `origin/main` (post PR #54 merge) showed zero
drift before this batch's own three documentation edits — Foundation, Identity &
Access, Patient Access, and every Phase 2B batch (PXP-1 through PXP-8, PXP-10) are
exactly as merged. Every batch's own file list was cross-checked against its own
disclosed scope in docs/44 §22 and the root `CHANGELOG.md`; no batch touched a file
outside what it disclosed, and every batch's own frozen-file exception (`login.html`,
`verify.html`, `my-health-journey/index.html`, `my-health-journey/dashboard.js` at
PXP-4, and the deprecation-by-documentation-only touch at PXP-10) was justified in
its own PR description at the time, per docs/47 §6.

---

# 5. Genuine Inconsistencies Found and Fixed

Three, all in docs/33-DOMAIN-MODEL.md, all documentation-only, none requiring a code
change, an architecture change, or a scope expansion — the same category of finding
docs/43 §5 recorded for Phase 2A's own closeout:

1. **§5.3 (Calculator)'s header status tag was stale.** Batch PXP-6 (2026-07-13)
   added a "Status update... Implemented — backend only" paragraph to this
   subsection's own body text, but never updated the subsection's `##` header itself,
   which still read *"Designed, not yet implemented — Patient variant only."* **Fix:**
   header updated to *"Implemented — backend only — Patient variant only (Phase 2B,
   Batch PXP-6, docs/44 §8)."*
2. **§6.4 was a stale, unmarked duplicate of §6.8.** When Batch PXP-6 shipped, its
   real, implemented shape was recorded in a **new** §6.8, rather than updating the
   original pre-implementation design in §6.4 in place. §6.4 was left carrying no
   status tag at all, silently disagreeing with the Summary Table (which already
   correctly pointed to §6.8 as the authoritative entity description).
   **Fix:** §6.4's header now reads *"Superseded by §6.8 (Batch PXP-6) — retained as
   pre-implementation history, not current,"* with an explanatory note added inline —
   the historical design text itself is kept, not deleted, per docs/00's "keep
   history, correct the stale current-status framing" rule, the same fix docs/43 §5
   applied to the old `docs/CHANGELOG.md`'s stale "Unreleased" framing.
3. **Section 6's own top-level header was stale.** It still read *"Designed, not yet
   implemented"* even though nine of its eleven subsections are now Implemented.
   **Fix:** updated to *"Mostly Implemented — see individual subsections and the
   Summary Table below."*

docs/33 was also bumped to Version 1.12 — it had not been version-bumped for Batch
PXP-10's own 2026-07-15 status-update content (§3.2, §6.3), a minor, disclosed gap in
that batch's own version-bump discipline, closed here rather than left for a future
batch to notice.

No other genuine inconsistency was found across the remaining docs/47 §14 review
dimensions (architecture, schema, contract, ADR, validation, and hygiene
consistency) — docs/24-ROADMAP.md and docs/31-ADR-INDEX.md were independently
checked against every shipped batch's own CHANGELOG entry and found already
accurate; no stale cross-reference, TODO/FIXME marker, temporary file, debug
artifact, or local path was found anywhere in `apps-script/`, `my-health-journey/`,
or `shared/`.

---

# 6. Security Review Record

Unlike Phase 2A (where the magic-link/session-token review was tracked as pending
and only actually performed at PA-7 closeout, docs/43 §5/§6), Phase 2B's one
genuinely new authentication mechanism — Trusted Device + Long-Lived Session
(Batch PXP-8) — already has its own dedicated review, performed and recorded at the
time that batch shipped: docs/15-SECURITY-STANDARDS.md, "Phase 2B — Implementation
Notes (Batch PXP-8, Trusted Device + Long-Lived Session)." This closeout re-confirms
that record against the current, unmodified source (`apps-script/TrustedDevice.gs`,
`apps-script/FoundationRouter.gs`'s four PXP-8 dispatch cases) rather than re-deriving
it — token entropy/hashing reuse (no new cryptographic bridge), rotation-not-mere-
single-use, generic rejection codes, cross-patient isolation, the
`sessionStorage`/`localStorage` split, and the disclosed revocation-latency
limitation were all independently re-verified as still true, not merely re-read.

**Optional PIN (`PatientCredential`) remains explicitly out of scope for all of
Phase 2B**, unchanged by this closeout — docs/45 Part 5's "requires its own dedicated
security review, independent of Trusted Device/Long-Lived Session" gate stays open
by design, not by omission, since PIN was never built by any shipped batch.

---

# 7. Deferred / Accepted, Not Reopened

Consistent with docs/00's "do not reopen earlier batches simply because a different
implementation is possible" — these remain open by design, not by omission, and this
batch did not touch them:

- **PXP-9 (AI Integration)** — remains an unbuilt, reserved placeholder. Any future
  AI feature is independently gated by ADR-001/004/005/013 when it is actually
  proposed, per docs/47 §2's "AI extension points only" rule — never smuggled in
  under a registry batch's own scope, and not something this closeout batch scopes
  either.
- **Optional PIN (`PatientCredential`)** — still requires its own dedicated security
  review (§6) before any future batch could build it; not built by PXP-8 or any
  later batch.
- **The Public (no-login) Calculator variant** — remains an unclaimed roadmap gap
  (docs/46 Part 3); only the Patient variant is claimed by Phase 2B, and only its
  backend (PXP-6).
- **Doctor, Appointment, Notification** — each remains "Conceptual (gap)" in
  docs/33-DOMAIN-MODEL.md, carried forward as reported gaps, not silently resolved.
- **Digital Twin** — explicitly not part of the Phase 2B batch sequence (docs/44
  §22); a later Phase 2D roadmap consumer of Timeline, Reports, Check-ins, Care
  Plans, and Calculators, not tightly coupled to Phase 2B's implementation.
- **Care Plan Timeline Event emission** — disclosed at PXP-7 as deliberately deferred
  (docs/44 §12 names this; emitting one would require touching two frozen Phase 2A
  files for new functionality, not a bug fix, per docs/47 §6). Unchanged by this
  closeout.
- docs/28's final governance sign-off ("Deployment approved") — a clinic decision,
  not a technical or documentation task; consistently disclosed since Phase 1.5.

---

# 8. Final Project Statistics (Phase 2B)

- **Completed batches:** 10 — PXP-1 through PXP-8, PXP-10, PXP-11 (this document).
  PXP-9 intentionally unbuilt (reserved placeholder, §1/§7).
- **Validation suites:** 13 — static analysis, conformance, Phase 1.5 regression, and
  10 browser-test suites (5 carried forward from Phase 2A, 5 new in Phase 2B:
  `pxp-1-patient-profile`, `pxp-4-dashboard-registry`, `pxp-5-checkin-engine`,
  `pxp-7-care-plan-engine`, `pxp-8-persistent-login`).
- **Total automated checks:** 710 (0 static-analysis findings + 419 conformance + 42
  Phase 1.5 regression + 249 browser-test checks across the 10 browser suites).
- **New shared schemas (Phase 2B):** 9 — `patient-profile`, `doctor-assigned-condition`,
  `patient-module-state`, `check-in-response`, `check-in-template-assignment`,
  `calculator-result`, `doctor-instruction`, `care-plan`, `trusted-device`.
- **New registry constants (Phase 2B):** 3 — `module-registry.json`,
  `template-registry.json`, `calculator-registry.json`.
- **New Apps Script modules (Phase 2B):** 12 — `FoundationPatientProfile.gs`,
  `DoctorAssignedCondition.gs`, `ModuleRegistry.gs`, `PatientModuleState.gs`,
  `TemplateRegistry.gs`, `CheckInResponse.gs`, `CheckInTemplateAssignment.gs`,
  `CalculatorRegistry.gs`, `CalculatorResult.gs`, `DoctorInstruction.gs`,
  `CarePlan.gs`, `TrustedDevice.gs`.
- **Total Apps Script modules (repository-wide):** 44.
- **New ADR (Phase 2B):** 1 — ADR-016 (Template Registry). Two existing ADRs
  amended (ADR-012, twice) and one superseded (ADR-014, by ADR-015).
- **Documentation closeout reports:** 5 — docs/35 (Foundation), docs/36 (Identity &
  Access), docs/38 (Patient Access Dashboard Shell), docs/43 (Phase 2A), docs/48
  (this document, Phase 2B).

---

# 9. Is Phase 2B Frozen?

**Yes — software-complete and frozen except for genuine bug fixes**, per docs/00's
Definition of Done and docs/47 §11's own Definition of Done: every shipped batch's
entities satisfy docs/47 §5 in full (schema, Apps Script module, documentation,
browser or conformance test coverage as appropriate, validation, CHANGELOG entry,
consistency review), every §7 validation suite passes cleanly on this batch's final
state (710/710), every §8 documentation obligation is satisfied, and no frozen file
was touched except for each batch's own disclosed, justified exception. PXP-9's slot
remains open — its non-existence is the designed, approved state, not a gap in this
freeze.

# 10. Is Phase 2B Production-Ready?

**Yes, for the scope docs/44 §22 defines and that actually shipped** (Patient
Profile, Doctor-Assigned Conditions, Module Registry, Dashboard Registry, Daily
Check-in Engine, Calculator Registry backend, Personal Care Plan, Trusted Device +
Long-Lived Session, Symptom Tracker Migration) — verified against the same real
conformance/regression/browser-test discipline Phase 2A's own production readiness
rested on. The same one open item Phase 2A already disclosed (docs/28's governance
sign-off) remains a non-blocking, non-technical gap; it does not gate Phase 2B's own
software readiness, exactly as it did not gate Phase 2A's.

# 11. Does Anything Block Public Release?

No known technical, architectural, schema, contract, or security blocker. See §7 for
what remains open by design (PXP-9, optional PIN, Public Calculator variant, and the
other named gaps) — none of these block the software that did ship.

# 12. Recommendation

**Tag this state `v2.1.0-phase2b`.** Next roadmap milestone: **Phase 2C — Health
Milestones** (docs/24) or a future, separately-proposed **PXP-9 — AI Integration**
design — either requires its own architecture-freeze pass (a technical plan and any
new ADRs it needs, per docs/44 §15's AI-specific gate for the latter) before
implementation begins. **Do not begin Phase 2C, a real PXP-9 design, or any other
Phase beyond PXP-11 without explicit, separate approval**, per docs/47 §9's
per-batch gate — the same discipline every batch since PXP-1 has already passed
through.
